Someone You Love: The HPV Epidemic - A Documentary

Specialties - Adolescent Medicine, Allergy and Immunology, Family Medicine, Hospice and Palliative Care, Hospitalist, Infectious Disease, Internal Medicine, Nursing, Obstetrics and Gynecology, Oncology, Pediatrics, Pharmacy, Public Health, Radiation Oncology

At the end of this activity, participants should be able to:

In support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and the Indiana Immunization Coalition. Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacists
Indiana University School of Medicine designates this activity for (ACPE UAN JA4008178-9999-21-009-H06-P; JA4008178-9999-21-009-H06-T) 1.5 ACPE contact hours. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

Physicians
Indiana University School of Medicine designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
Indiana Immunization Coalition (IIC) is approved as a provider of nursing continuing professional development by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. (OBN-001-91). This activity is approved for 1.91 Contact Hours (for live view), and 1.3 Contact Hours (for online view).

Complete evaluation and receive Nursing CNE certificate of completion: https://www.surveymonkey.com/r/HPVCNEEval


Bibliography References:

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices Elissa Meites, MD1; Peter G. Szilagyi, MD2; Harrell W. Chesson, PhD3; Elizabeth R. Unger, PhD, MD4; José R. Romero, MD5; Lauri E. Markowitz, MD1   MMWR / August 16, 2019 / Vol. 68 / No. 32 US Department of Health and Human Services/Centers for Disease Control and Prevention

https://www.cdc.gov/cancer/hpv/statistics/cases.htm

https://www.cdc.gov/cancer/uscs/about/data-briefs/no10-hpv-assoc-cancers-UnitedStates-2012-2016.htm

https://www.cdc.gov/cancer/uscs/about/data-briefs/no6-hpv-assoc-cancers-AIAN-UnitedStates-1999-2015.htm

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838063/

International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 90: Human papillomaviruses.external icon Lyon, France: International Agency for Research on Cancer, World Health Organization; 2007.

Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS. Anal cancer incidence in the United States, 1977–2011: distinct patterns by histology and behavior. Cancer Epidemiology, Biomarkers and Prevention 2015;24:1548–1556.

Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M, Centers for Disease Control and Prevention (CDC). Human papillomavirus–associated cancers—United States, 2008–2012. MMWR 2016;65(26):661–666.Supplement: Assessing the Burden of HPV-Associated Cancers in the United States.external icon Cancer 2008;113(S10):2837–3057.

Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT; HPV Typing of Cancers Workgroup. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.external icon Journal of the National Cancer Institute 2015;107:djv086.